BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17115121)

  • 1. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis.
    Garbern JY
    Cell Mol Life Sci; 2007 Jan; 64(1):50-65. PubMed ID: 17115121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ
    Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY
    J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
    [No Abstract]   [Full Text] [Related]  

  • 4. Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; Thomson G; Penderis J; Edgar JM
    J Anat; 2011 Jul; 219(1):33-43. PubMed ID: 21401588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
    Inoue K
    Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
    Hudson LD
    J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
    Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
    Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PLP mutants from mouse to man.
    Duncan ID
    J Neurol Sci; 2005 Feb; 228(2):204-5. PubMed ID: 15694207
    [No Abstract]   [Full Text] [Related]  

  • 10. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
    Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
    Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
    Laukka JJ; Kamholz J; Bessert D; Skoff RP
    Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenetics of Pelizaeus-Merzbacher disease.
    Osório MJ; Goldman SA
    Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
    Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
    J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
    Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
    Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
    Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
    Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.